Loading...
AVITA Medical, Inc.
RCEL•NASDAQ
Healthcare
Medical - Devices
$5.77
$-0.21(-3.51%)
AVITA Medical, Inc. (RCEL) Financial Performance & Income Statement Overview
Review AVITA Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
28.14%
↑ 28.14%
Operating Income Growth
-32.68%
↓ 32.68%
Net Income Growth
-74.80%
↓ 74.80%
Operating Cash Flow Growth
-28.75%
↓ 28.75%
Operating Margin
-88.08%
↓ 88.08%
Gross Margin
85.85%
↑ 85.85%
Net Profit Margin
-96.26%
↓ 96.26%
ROE
-337.90%
↓ 337.90%
ROIC
-95.03%
↓ 95.03%
AVITA Medical, Inc. (RCEL) Income Statement & Financial Overview
Review AVITA Medical, Inc.'s (RCEL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18.41M | $19.55M | $15.20M | $11.10M |
| Cost of Revenue | $2.28M | $3.19M | $2.11M | $1.51M |
| Gross Profit | $16.13M | $16.36M | $13.08M | $9.59M |
| Gross Profit Ratio | $0.88 | $0.84 | $0.86 | $0.86 |
| R&D Expenses | $4.85M | $5.43M | $4.89M | $5.19M |
| SG&A Expenses | $21.23M | $24.73M | $23.82M | $21.60M |
| Operating Expenses | $26.08M | $30.16M | $28.71M | $26.80M |
| Total Costs & Expenses | $28.36M | $33.35M | $30.82M | $28.31M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.30M | $1.36M | $1.35M | $1.36M |
| Depreciation & Amortization | $409000.00 | $310000.00 | $204000.00 | $203000.00 |
| EBITDA | -$9.86M | -$14.56M | -$13.81M | -$17.07M |
| EBITDA Ratio | -$0.54 | -$0.75 | -$0.91 | -$1.54 |
| Operating Income | -$9.96M | -$13.81M | -$15.62M | -$17.21M |
| Operating Income Ratio | -$0.54 | -$0.71 | -$1.03 | -$1.55 |
| Other Income/Expenses (Net) | -$1.61M | -$2.43M | $264000.00 | -$1.42M |
| Income Before Tax | -$11.57M | -$16.23M | -$15.36M | -$18.63M |
| Income Before Tax Ratio | -$0.63 | -$0.83 | -$1.01 | -$1.68 |
| Income Tax Expense | $19000.00 | -$28000.00 | $33000.00 | $30000.00 |
| Net Income | -$11.59M | -$16.20M | -$15.39M | -$18.66M |
| Net Income Ratio | -$0.63 | -$0.83 | -$1.01 | -$1.68 |
| EPS | -$0.44 | -$0.62 | -$0.60 | -$0.73 |
| Diluted EPS | -$0.44 | -$0.62 | -$0.60 | -$0.73 |
| Weighted Avg Shares Outstanding | $26.15M | $25.98M | $25.76M | $25.64M |
| Weighted Avg Shares Outstanding (Diluted) | $26.15M | $25.98M | $25.76M | $25.64M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan